SANUWAVE Health Inc. (SNWV) is a Medical/Dental Instruments company listed on NASDAQ. In the last 30 days Quantisnow tracked 5 wire items for SNWV, including 5 insider trades. The most recent was published Oct 2, 2026.
News · 26 weeks27-100%
2026-05-032026-10-25
Mix1090d
- Insider5(50%)
- SEC Filings3(30%)
- Earnings2(20%)
Latest news
25 items- INSIDERSEC Form 4 filed by Director Tyler James4 - SANUWAVE Health, Inc. (0001417663) (Issuer)
- INSIDERSEC Form 4 filed by Chief Executive Officer Frank Morgan C.4 - SANUWAVE Health, Inc. (0001417663) (Issuer)
- INSIDERSEC Form 4 filed by Director Bazar Gregory Matthew4 - SANUWAVE Health, Inc. (0001417663) (Issuer)
- INSIDERSEC Form 4 filed by Director Blizard Jeffrey4 - SANUWAVE Health, Inc. (0001417663) (Issuer)
- INSIDERSEC Form 4 filed by Director Miller Ian D.4 - SANUWAVE Health, Inc. (0001417663) (Issuer)
- SECSANUWAVE Health Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing8-K - SANUWAVE Health, Inc. (0001417663) (Filer)
- SECSANUWAVE Health Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - SANUWAVE Health, Inc. (0001417663) (Filer)
- PRSanuwave Announces Q2 FY2026 Financial ResultsQ2 2026 revenues were $9.7 million, down 3% from $10.1 million in Q2 2025. Q2 2026 gross margin was 76.2%, versus 78.1% in Q2 2025. GAAP Operating (Loss) Income was $(0.3) million for Q2 2026 versus $1.4 million in Q2 2025. EDEN PRAIRIE, Minn., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the "Company" or "Sanuwave") (NASDAQ:SNWV), a leading provider of next-generation FDA-cleared wound care products, is pleased to provide its financial results for the three months ended June 30, 2026. Quarter ended June 30, 2026 Revenue for the three months ended June 30, 2026, totaled $9.7 million, an decrease of 3%, as compared to $10.1 million for the same period of 2025.
- SECSEC Form 10-Q filed by SANUWAVE Health Inc.10-Q - SANUWAVE Health, Inc. (0001417663) (Filer)
- PRSanuwave Will Host a Conference Call on August 7, 2026 at 8:30 AM (ET) to Present Q2 2026 Financial ResultsEDEN PRAIRIE, Minn., July 30, 2026 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the "Company" or "Sanuwave") (NASDAQ:SNWV), a leading provider of next-generation FDA-approved wound care products, will host a live conference call on Friday, August 7, 2026, at 8:30 AM (ET) to present its Q2 2026 financial results. Telephone access to the call will be available by dialing the following numbers: Participant Dial-in Information Toll Free: 1-800-274-8461Toll/International: 1-203-518-9814Conference ID: SANUWAVE OR click the link below to access the live webcast:https://viavid.webcasts.com/starthere.jsp?ei=1771327&tp_key=110b588de5Materials for the conference call will be included on the Company’
- SECSANUWAVE Health Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - SANUWAVE Health, Inc. (0001417663) (Filer)
- PRSanuwave Health Reports Preliminary Q2 2026 Revenue of $9.6–$9.8 Million, Above High End of Revised GuidanceEDEN PRAIRIE, Minn., July 13, 2026 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the "Company" or "Sanuwave") (NASDAQ:SNWV), a leading provider of FDA-cleared directed energy systems used in advanced wound care, today announced that revenues for the second quarter of 2026 are expected to be in the range of $9.6 to $9.8 million, above the high end of the revised guidance range of $8.5 to $9.5 million provided in the Company’s press release dated June 16, 2026. Preliminary second quarter revenues represent a decrease of approximately 3–5% from revenues of $10.1 million in the second quarter of 2025. "Q2 came in a bit above the top of the range that we laid out back in June," said CEO Morgan Fr
- INSIDERSEC Form 4 filed by Director Blizard Jeffrey4 - SANUWAVE Health, Inc. (0001417663) (Issuer)
- INSIDERSEC Form 4 filed by Director Miller Ian D.4 - SANUWAVE Health, Inc. (0001417663) (Issuer)
- INSIDERSEC Form 4 filed by Director Bazar Gregory Matthew4 - SANUWAVE Health, Inc. (0001417663) (Issuer)
- INSIDERSEC Form 4 filed by Director Tyler James4 - SANUWAVE Health, Inc. (0001417663) (Issuer)
- INSIDERSEC Form 4 filed by Chief Executive Officer Frank Morgan C.4 - SANUWAVE Health, Inc. (0001417663) (Issuer)
- SECSANUWAVE Health Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - SANUWAVE Health, Inc. (0001417663) (Filer)
- PRSanuwave Health Updates Second Quarter 2026 GuidanceSanuwave updates guidance for Q2 2026 to $8.5 - $9.5 million Company on pace for record unit sales of applicators in Q2 Market disruption impacting Ultramist system sales EDEN PRAIRIE, Minn., June 16, 2026 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the "Company" or "Sanuwave") (NASDAQ:SNWV), a leading provider of FDA-cleared directed energy systems used in advanced wound care, today announced that revenues for the second quarter of 2026 are expected to be in the range of $8.5 to $9.5 million, below the guidance provided on the Q1 earnings call on May 13 of this year. "In the time since we had our Q1 call, we have seen material changes in the conditions in the capital equipment market f
- SECSANUWAVE Health Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - SANUWAVE Health, Inc. (0001417663) (Filer)
- SECSEC Form SD filed by SANUWAVE Health Inc.SD - SANUWAVE Health, Inc. (0001417663) (Filer)
- PRSanuwave Announces Revenues and Financial Results for Q1 FY2026Q1 2026 revenues were $9.6 million, up 3.1% from $9.3 million in Q1 2025. This represents the highest Q1 quarterly revenues in Company history. Q1 2026 gross margin was 77.3%, versus 79.0% in Q1 2025. GAAP Operating Loss was $1.1 million for Q1 2026, a swing of $1.7 million from operating income of $0.6 million in Q1 2025. Company provides guidance for revenue growth of 10-15% for Q2 2026 as compared to Q2 2025 EDEN PRAIRIE, Minn., May 12, 2026 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the "Company" or "Sanuwave") (NASDAQ:SNWV), a leading provider of next-generation FDA-approved wound care products, is pleased to provide its financial results for the three months ended March 31, 2026
- SECSANUWAVE Health Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - SANUWAVE Health, Inc. (0001417663) (Filer)
- SECSEC Form 10-Q filed by SANUWAVE Health Inc.10-Q - SANUWAVE Health, Inc. (0001417663) (Filer)
- PRSanuwave Will Host a Conference Call on May 13, 2026 at 8:30 AM (ET) to Present Q1 2026 Financial ResultsEDEN PRAIRIE, Minn., May 06, 2026 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the "Company" or "Sanuwave") (NASDAQ:SNWV), a leading provider of next-generation FDA-approved wound care products, will host a live conference call on Wednesday, May 13, 2026, at 8:30 AM (ET) to present its Q1 2026 financial results. Telephone access to the call will be available by dialing the following numbers: Participant Dial-in Information Toll Free: 1-833-316-1983 Toll/International: 1-785-838-9310 Conference ID: SANUWAVE OR click the link below to access the live webcast:https://viavid.webcasts.com/starthere.jsp?ei=1762392&tp_key=537d7338d6 Materials for the conference call will be included on the
SNWV FAQ
6 questionsWhat is the latest news on SNWV?
In the last 30 days Quantisnow tracked 5 wire items for SNWV: 5 insider trades. The most recent was published on October 2, 2026.Where does SNWV stock trade?
SANUWAVE Health Inc. (SNWV) is listed on NASDAQ.What sector and industry is SNWV in?
SANUWAVE Health Inc. operates in the Health Care sector, Medical/Dental Instruments industry.What are analysts saying about SNWV?
SANUWAVE Health Inc. has had 2 recent analyst actions on file. The most recent action was from Northland Capital: Outperform on 2025-09-03. Recent price targets cluster around $4900.00.What companies are similar to SNWV?
Notable peers in the same industry include SYK (Stryker Corporation), MMM (3M Company), BSX (Boston Scientific Corporation), BDX (Becton Dickinson and Company), MDLN (Medline Inc.). Compare SNWV side-by-side with any of them on Quantisnow.How can I track SNWV on Quantisnow?
Quantisnow aggregates SANUWAVE Health Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow SNWV to receive live email and push alerts on every new disclosure.